Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin (Q73456991)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202362%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202362%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

main subject

intravascular ultrasound

1 reference

T Takagi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202362%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

K Yoshida

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202362%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

T Akasaka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202362%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

T Hozumi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202362%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S Morioka

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202362%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J Yoshikawa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202362%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 June 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202362%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202362%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202362%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202362%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

1673-1676

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202362%20AND%20SRC:MED&resulttype=core&format=json

Coronary artery imaging with intravascular high-frequency ultrasound

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900221-X

Arterial wall characteristics determined by intravascular ultrasound imaging: an in vitro study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900221-X

Intracoronary ultrasound imaging: intraobserver and interobserver variability of morphometric measurements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900221-X

Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900221-X

Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemia and familial combined hyperlipidemia: correlation with high density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900221-X

Intravascular ultrasound imaging: in vitro validation and pathologic correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900221-X

Assessment of normal and atherosclerotic arterial wall thickness with an intravascular ultrasound imaging catheter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900221-X

Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900221-X

Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900221-X

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900221-X

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900221-X

Are we mortgaging the medical profession?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900221-X

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900221-X

Changes in cardiovascular risk profile during the cessation of smoking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900221-X

10.1016/S0002-9149(97)00221-X

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202362%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference